Search results for "Prostate Cancer"
Letters to the Editor
disease, with the rationale being that perhaps we will detect an early ovarian cancer? ... prostate cancer, cannot.
March 2010
Losing it: A rational approach to hair loss
high-grade prostatic carcinoma was reduced, but there was a possible increased risk in those who had prostate cancer, she said. ... When screening for prostate cancer in patients taking finasteride, Dr. Malerich suggested increasing the prostate-specific
June 2019
Squeezing in the cancer screening talk
We have evidence, and practitioners should use that to improve cancer screening rates. ... When Dr. Mulhausen told an 86-year-old man he didn't need to screen for prostate cancer, for example, the patient responded, “So you're just going to give up
October 2019
Propoxyphene withdrawn, bevacizumab loses indication
In trials of patients with breast and prostate cancer, denosumab increased the length of time to SRE compared to zoledronic acid (Zometa). ... The breast cancer indication for bevacizumab was approved in February 2008 under the FDA's accelerated approval
February 2011
Points to consider in palliative care
Start with basic internal medicine. If an older patient with metastatic hormone-refractory prostate cancer has heart failure and shortness of breath, the best palliative care may be to treat his ... For instance, the patient may have a pulmonary embolism
July 2018
Catheters, infusion pumps recalled
Relugolix (Orgovyx) for the treatment of adult patients with advanced prostate cancer. ... In a randomized, open-label trial, 96.7% of 622 men with advanced prostate cancer who received the drug achieved and maintained low enough levels of testosterone.
February 2021
Decision aids integral to shared decision making
for selecting a depression medication or deciding whether to have prostate cancer screening. ... Gutnick. Dr. Soung, for example, uses them for deciding about CT scans for lung cancer screening, medications for osteoporosis and depression, second-line
May 2019
Warnings on prostate drugs, HIV combination therapy
New warnings on gonadotropin-releasing hormone (GnRH) agonists about the potential risk of heart disease and diabetes in men treated with these medications for prostate cancer.
January 2011
Dealing with dementia, Q&As on COVID-19
The therapy comes with its own potential risks, too, including a possible link to cardiovascular disease and prostate cancer.
May 2020
Peanut butter recall issued, reminder for topical anesthetics
Degarelix, a new injectable drug to treat advanced prostate cancer by suppressing testosterone. ... Imatinib mesylate (Gleevec), to stop cancer from growing after surgical removal of a gastrointestinal stromal tumor.
March 2009